Exercise Program for Gynecologic Cancer
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems focused on increasing physical activity for cancer patients, so it's best to discuss your medications with the trial team.
Research shows that exercise interventions can improve physical and mental health outcomes for women during and after gynecological cancer treatment. Additionally, physical activity is linked to better quality of life in ovarian cancer survivors, and a Fitbit program has been effective in increasing physical activity among endometrial cancer survivors.
12345The research does not specifically address safety concerns, but exercise programs like these are generally considered safe for cancer survivors and can improve health outcomes.
12356The Fit4Treatment exercise program is unique because it focuses on physical activity to improve health outcomes for women with gynecologic cancer, unlike traditional treatments that may focus on medication or surgery. This program aims to enhance physical and psychosocial well-being during and after cancer treatment, which is not typically addressed by standard medical treatments.
13467Eligibility Criteria
This trial is for women over 60 with gynecologic cancers (endometrial/uterine, ovarian, cervical, vulvar/vaginal) who are fluent in English and undergoing systemic treatments like chemotherapy. They should be able to participate in physical activities and find an exercise partner if needed.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week physical activity intervention using a wearable activity tracker and app, with components such as coaching, provider engagement, exercise partner, and symptom-burden tailored goal setting
Follow-up
Participants are monitored for changes in physical activity, quality of life, and other health outcomes after the intervention
Long-term Follow-up
Participants' health outcomes, including adverse events and survival, are monitored through medical record review